Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Indian Journal of Pharmaceutical Sciences|April 15, 2010
A decision tree for rapid quality assurance and control of rifampicin-containing oral dosage forms for global distribution for tuberculosis treatmentY Ashokraj, Shrutidevi Agrawal, R Panchagnula
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 13, 2005
Quality control of anti-tuberculosis FDC formulations in the global market: part II-accelerated stability studiesY Ashokraj, G Kohli, C L Kaul, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 15, 2005
Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatmentY Ashokraj, I Singh, K J Kaur, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2005
Plasma pooling: utility in expediting bioequivalence assessment of rifampicin-containing fixed-dose combinationsY Ashokraj, I Singh, K J Kaur, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 1, 2004
Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro studyY Ashokraj, S Agrawal, M V S Varma, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 6, 2005
Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspectiveR Panchagnula, S Agrawal, Y Ashokraj, et al.
Pageof 1